SCARB1 and metabolic disease: When patients from the CAPIRE study were stratified based on the number of RFs, SR-BI-mediated cholesterol efflux capacity correlated better with inflammatory markers in the low-RF cohort, whereas in the multiple-RF cohort it mainly correlated with markers of metabolic disorders.